Literature DB >> 4380339

Neurochemical bases of tremor and other disorders of movement.

T L Sourkes, L J Poirier.   

Abstract

Monkeys inflicted with specific unilateral electrolytic lesions in the upper brain stem developed extrapyramidal disorders. Hypokinesia of the limbs was associated contralaterally with a lesion of the substantia nigra and depletion of striatal dopamine. Choreiform movements were observed in animals that had, contralaterally, a lesion severing the most dorsomedial fibres of the cerebral peduncle and the rubro-tegmentospinal tract, associated with depletion of striatal serotonin. Monkeys showing sustained postural tremor and hypokinesia had lesions affecting these three tracts contralaterally and loss of striatal dopamine and serotonin on the lesion side. Of many drugs tested, only harmaline and harmine affected the dyskinesias. The nigrostriatal fibres appear to be dopaminergic; the cerebral peduncular (dorsomedial) fibres, serotoninergic. The role of striatal dopamine and serotonin in the control of normal movements and posture of the limbs represents the first directly demonstrated function of these amines in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4380339      PMCID: PMC1935214     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  33 in total

1.  INTERRELATIONSHIPS BETWEEN AMPHETAMINE AND HARMALA ALKALOIDS.

Authors:  H SCHMITT; H SCHMITT
Journal:  Nature       Date:  1964-08-22       Impact factor: 49.962

2.  A CONTROLLED CLINICAL TRIAL OF ALPHA METHYL DOPA IN PARKINSONIAN TREMOR.

Authors:  D O MARSH; H SCHNIEDEN; J MARSHALL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-12       Impact factor: 10.154

3.  [EXPERIENCES WITH L-DOPA IN THE THERAPY OF PARKINSONISM].

Authors:  F GERSTENBRAND; K PATEISKY; P PROSENZ
Journal:  Psychiatr Neurol (Basel)       Date:  1963

4.  INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM.

Authors:  L J POIRIER; T L SOURKES
Journal:  Brain       Date:  1965-03       Impact factor: 13.501

5.  Determination of catecholamines and catecholamino acids by differential spectrophotofluorimetry.

Authors:  T L SOURKES; G F MURPHY
Journal:  Methods Med Res       Date:  1961

6.  Intracellular distribution of catecholamines in the brain.

Authors:  H WEIL-MALHERBE; A D BONE
Journal:  Nature       Date:  1957-11-16       Impact factor: 49.962

7.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

8.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

9.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

10.  [On dopamine (hydroxytyramine) metabolism in the rat brain].

Authors:  G HOLZER; O HORNYKIEWICZ
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1959
View more
  4 in total

1.  Brain amines, and their acids in the cerebrospinal fluid.

Authors: 
Journal:  Can Med Assoc J       Date:  1967-03-04       Impact factor: 8.262

2.  Glucuronidation of 3-O-methylnoradrenaline, harmalol and some related compounds.

Authors:  K P Wong; T L Sourkes
Journal:  Biochem J       Date:  1968-11       Impact factor: 3.857

3.  Dopamine (3-hydroxytyramine) metabolism in parkinsonism.

Authors:  M Goodall; H Alton
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

Review 4.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.